CONTENTS:
• Quasi-legal cannabis in Colorado and Washington: local and national implications [Editorial]. Hawken A., Caulkins J., Kilmer B., Kleiman M., p. 837-838.
• Random student drug testing as a school-based drug prevention strategy [For debate]. DuPont R.L., Merlo L.J., Arria A.M., Shea C.L., p. 839-845.
• Limited evidence: Many pitfalls. Gilvarry E., p. 846-847.
• Values, compelling ideas, the pace of science, and the implementation of evidence-based policy. Galea S., p. 847-848.
• Exploring the promise of mandatory random student drug testing by comparing it to other school drug prevention strategies. Sznitman S.R., p. 848-850.
• Response to commentaries on random student drug testing. DuPont R.L., Merlo L.J., Arria A.M., Shea C.L., p. 850-851.
• Vested Interests in Addiction Research and Policy. Alliance between tobacco and alcohol industries to shape public policy. Jiang N., Ling P., p. 852-864.
• Conversation with Robert Voas. 865-873.
• Efficacy combined with specified ingredients: a new direction for empirically supported addiction treatment. Magill M., Longabaugh R., p. 874-881.
• Commentary on Magill & Longabaugh (2013): Specifying the active ingredients in evidence-based treatments - setting the bar too high? McKay J.R., p. 882-883.
• Response to McKay: The stakes are high. Magill M., Longabaugh R., p. 883-884.
• Local government alcohol policy development: case studies in three New Zealand communities. Maclennan B., Kypri K., Room R., Langley J., p. 885-895.
• Commentary on Maclennan et al. (2013): Evolution of local alcohol policy research. What's next? Wolfson M., p. 896-897.
• Commentary on Maclennan et al. (2013): Is local alcohol policy possible? Sulkunen P., p. 898-899.
• A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Alessi S.M., Petry N.M., p. 900-909.
• Commentary on Alessi & Petry (2013): Cellular phone technology and contingency management. Kong G., p. 910-911.
• Global alcohol exposure estimates by country, territory and region for 2005 - a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Shield K.D., Rylett M., Gmel G., Gmel G., Kehoe-Chan T.A.K., Rehm J., p. 912-922.
• Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder? Kaye S., Darke S., Torok M., p. 923-931.
• Commentary on Kaye et al. (2013): Attention deficit disorder in substance use disorder - a hidden or a conspicuous comorbidity? What does it change for patients? Garcia F.D., p. 932-933.
• The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Latkin C., Donnell D., Liu T.-Y., Davey-Rothwell M., Celentano D., Metzger D., p. 934-943.
• High rates of midazolam injection and associated harms in Bangkok, Thailand. Hayashi K., Suwannawong P., Ti L., Kaplan K., Wood E., Kerr T., p. 944-952.
• The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Boileau I., Payer D., Chugani B., Lobo D., Behzadi A., Rusjan P.M., et al., p. 953-963.
• Commentary on Boileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions. Potenza M.N., Brody A.L., p. 964-965.
• A randomized controlled trial of a smoking cessation intervention conducted among prisoners. Richmond R., Indig D., Butler T., Wilhelm K., Archer V., Wodak A., p. 966-974.
• Commentary on Richmond et al. (2013): Cessation treatment for prisoners. Hall S., p. 975-976.
• Investigating the impact of nicotine on executive functions using a novel virtual reality assessment. Jansari A.S., Froggatt D., Edginton T., Dawkins L., p. 977-984.
• Think abstractly, smoke less: a brief construal-level intervention can promote self-control, leading to reduced cigarette consumption among current smokers. Chiou W.-B., Wu W.-H., Chang M.-H., p. 985-992.
• Childhood sexual abuse and early substance use in adolescent girls: the role of familial influences. Sartor C.E., Waldron M., Duncan A.E., Grant J.D., McCutcheon V.V., Nelson E.C., et al., p. 993-1000.
• Commentary on Sartor et al. (2013): Trauma and drug use - more evidence for self-medication? Darke S., p. 1001.
• The importance of indirect screening and objective gold standards: a response to Terplan (2012). Ondersma S.J., Svikis D.S., LeBreton J.M., Streiner D.L., Grekin E.R., Lam P.K., et al., p. 1002.
• Methods reporting in human laboratory studies. Maynard O.M., Munafò M.R., p. 1002-1003.